Repligen (RGEN) Cost of Revenue (2010 - 2026)

Repligen (RGEN) has 17 years of Cost of Revenue data on file, last reported at $86.0 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 10.5% year-over-year to $86.0 million in Q1 2026; TTM through Mar 2026 was $359.6 million, a 0.45% change from a year earlier, with the FY2025 full-year figure at $352.0 million, down 2.16% from the prior year.
• Cost of Revenue for Q1 2026 stood at $86.0 million, down from $94.1 million in the prior quarter.
• Over the last five years, Cost of Revenue for RGEN reached as high as $128.7 million in Q4 2024 and fell as low as $76.4 million in Q1 2024.
• Historically, Cost of Revenue has averaged $88.1 million across 5 years, with a median of $86.3 million in 2022.
• Across the five-year window, Cost of Revenue surged 46.03% in 2024 and dropped 26.9% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $90.7 million in 2022, then retreated by 2.83% to $88.1 million in 2023, then jumped by 46.03% to $128.7 million in 2024, then fell by 26.9% to $94.1 million in 2025, then declined by 8.62% to $86.0 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $86.0 million in Q1 2026, $94.1 million in Q4 2025, and $88.3 million in Q3 2025.